NO754028L - - Google Patents
Info
- Publication number
- NO754028L NO754028L NO754028A NO754028A NO754028L NO 754028 L NO754028 L NO 754028L NO 754028 A NO754028 A NO 754028A NO 754028 A NO754028 A NO 754028A NO 754028 L NO754028 L NO 754028L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- group
- alkyl
- formula
- 7ars
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 150000002431 hydrogen Chemical class 0.000 claims description 13
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 11
- 229910052801 chlorine Inorganic materials 0.000 claims description 11
- 239000000460 chlorine Substances 0.000 claims description 11
- -1 tyr hydrogen Chemical class 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 239000011737 fluorine Substances 0.000 claims description 9
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229910052987 metal hydride Inorganic materials 0.000 description 3
- 150000004681 metal hydrides Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000005932 reductive alkylation reaction Methods 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- 150000001728 carbonyl compounds Chemical class 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-M malonate(1-) Chemical compound OC(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-M 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- RCMLKQSZCSYLLS-UHFFFAOYSA-N 1-hydroxy-2,3-dihydroindole Chemical compound C1=CC=C2N(O)CCC2=C1 RCMLKQSZCSYLLS-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 230000006181 N-acylation Effects 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- ZOOSILUVXHVRJE-UHFFFAOYSA-N cyclopropanecarbonyl chloride Chemical compound ClC(=O)C1CC1 ZOOSILUVXHVRJE-UHFFFAOYSA-N 0.000 description 1
- 238000005661 deetherification reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- XTEGVFVZDVNBPF-UHFFFAOYSA-L naphthalene-1,5-disulfonate(2-) Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1S([O-])(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-L 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000005359 phenoxyalkyl group Chemical group 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Fremgangsmåte for fremstilling av nye organiske forbindelser. Procedure for the production of new organic compounds.
Foreliggende oppfinnelse vedrorer en fremgangsmåte for fremstilling av nye forbindelser med formel I The present invention relates to a method for the production of new compounds with formula I
hvori in which
IL betyr hydrogen, alkyl med 1 - h karbonatomer, alkoksy med 1 - h-karbonatomer, fluor, klor eller hydroksy og IL means hydrogen, alkyl with 1 - h carbon atoms, alkoxy with 1 - h carbon atoms, fluorine, chlorine or hydroxy and
R2betyr alkyl med 1 - h- karbonatomer, alkenyl med 3-7 karbonatomer eller alkynyl med 3-7 karbonatomer, hvis umettede binding ikke befinner seg i ct-stilling til det nitrogenatom hvortil alkenyl eller alkynyl-gruppen er bundet, cykloalkyl med 5-7 karbonatomer, med cykloalkyl med 2>- 7J karbonatomer monosubstituert alkyl med 1-hkarbonatomer, hydroksyalkyl med 2- h karbonatomer, hvis hydroksy-gruppe er skilt fra det nitrogenatom hvortil hydroksyalkylgruppen er bundet ved minst 2 karbonatomer, en gruppe (CR^p-CO-A, hyori R2 means alkyl with 1 - h carbon atoms, alkenyl with 3-7 carbon atoms or alkynyl with 3-7 carbon atoms, whose unsaturated bond is not in the ct position of the nitrogen atom to which the alkenyl or alkynyl group is attached, cycloalkyl with 5-7 carbon atoms, with cycloalkyl with 2>-7J carbon atoms monosubstituted alkyl with 1-h carbon atoms, hydroxyalkyl with 2- h carbon atoms, whose hydroxy group is separated from the nitrogen atom to which the hydroxyalkyl group is bonded by at least 2 carbon atoms, a group (CR^p-CO -Ah, hyori
p er et helt tall fra 1 til 3 ogp is an integer from 1 to 3 and
A betyr alkyi med 1-kkarbonatomer eller alkoksy med 1- h karbonatomer, eller A means alkyl with 1-k carbon atoms or alkoxy with 1-h carbon atoms, or
R^og R^_ betyr hydrogen, alkyl med 1 - h karbonatomer, alkoksy med 1karbonatomer eller halogen og R^ and R^_ mean hydrogen, alkyl with 1 - h carbon atoms, alkoxy with 1 carbon atoms or halogen and
enten X står for en enkelt binding, vinylen- eller karbonyl-gruppen og n står for et helt tall fra 1 til 55either X stands for a single bond, the vinylene or carbonyl group and n stands for an integer from 1 to 55
eller X betyr en gruppe av rekken -0-, -S-, -SO-, -S02- eller -NR^og n er et helt tall fra 2 til 5, idet R^står for hydrogen, fenyl, alkyl med 1 - h karbonatomer eller aTkanoyl med 2 - h karbonatomer. or X means a group of the series -O-, -S-, -SO-, -SO2- or -NR^ and n is an integer from 2 to 5, R^ standing for hydrogen, phenyl, alkyl with 1 - h carbon atoms or aTkanoyl with 2 - h carbon atoms.
Mulig forekommende alkyl- henholdsvis alkoksyrester inneholder foretrukket 1 eller 2, spesielt 1 karbonatom. Possible alkyl or alkoxy residues preferably contain 1 or 2, especially 1 carbon atom.
R^betyr foretrukket hydrogen, alkyl, alkoksy, fluor eller klor.R2 preferably means hydrogen, alkyl, alkoxy, fluorine or chlorine.
R0 står foretrukket for de ovenfor definerte grupper alkyl, alkenyl, R0 preferably stands for the above-defined groups alkyl, alkenyl,
hydroksyalkyl, -(CH ) -C0A eller hydroxyalkyl, -(CH ) -COA or
Står R2 Standing R2
for den ovenfor definerte hydroksy alkyl-gruppe, inneholder denne foretrukket 2 eller 3 karbonatomer. Står for en gruppe (CH^p-COA, betyr p foretrukket tallet 2 eller 3. Står R2for den ovenfor definerte cykloalkyl-alkylgruppe, betyr denne rest foretrukket cyklopropylmetyl. for the hydroxy alkyl group defined above, this preferably contains 2 or 3 carbon atoms. Stands for a group (CH^p-COA, p preferably means the number 2 or 3. If R2 stands for the cycloalkyl-alkyl group defined above, this residue preferably means cyclopropylmethyl.
A står foretrukket for en alkylgruppe.A preferably stands for an alkyl group.
X står foretrukket for en enkelt binding eller en gruppe av rekken -0-, -S-, -SO^- eller -CO-, spesielt for en enkelt binding eller en karbonylgruppe. Står X for en enkelt binding eller vinylen, betyr n foretrukket et helt tall fra 1 - h. Står- X X preferably stands for a single bond or a group of the series -O-, -S-, -SO^- or -CO-, especially for a single bond or a carbonyl group. If X stands for a single bond or vinylene, n preferably means a whole number from 1 - h. Stands for X
for en gruppe av rekken -0-, -S-, -SO-, -S02~, -CO- eller -NR^-, betyr n foretrukket tallet 2 eller 3. Står R^for alkanoyl med 2- h karbonatomer, inneholder denne rest foretrukket 2 eller 3 karbonatomer. for a group of the series -O-, -S-, -SO-, -SO2~, -CO- or -NR^-, n preferably means the number 2 or 3. If R^ stands for alkanoyl with 2- h carbon atoms, contains this residue preferably 2 or 3 carbon atoms.
R^betyr foretrukket hydrogen, halogen eller en alkylgruppe.R^ preferably means hydrogen, halogen or an alkyl group.
R^_ står foretrukket for hydrogen. Står R^ og/eller R^for halogen betyr disse rester fluor, klor eller brom, foretrukket fluor eller R^_ preferably stands for hydrogen. If R^ and/or R^ stand for halogen, these residues mean fluorine, chlorine or bromine, preferably fluorine or
■ klor.■ chlorine.
Det særegne ved fremgangsmåten i henhold til oppfinnelsen er at The peculiarity of the method according to the invention is that
a) i 1-stillingen av forbindelser med formel IIa) in the 1-position of compounds of formula II
hvori R^har den ovennevnte betydning, innfores en gruppe R^ in which R^ has the above meaning, a group R^ is introduced
med den ovennevnte betydning ellerwith the above meaning or
b) for fremstilling av forbindelse med formel Ia,b) for the preparation of compound of formula Ia,
hvori R;j" betyr hydrogen, alkyl med 1 - h karbonatomer, alkoksy med 1 -*f .karbonatomer, fluor eller klor og in which R;j" means hydrogen, alkyl with 1 - h carbon atoms, alkoxy with 1 -*f . carbon atoms, fluorine or chlorine and
E betyr hydrogen, alkyl med 1-3 karbonatomer, cykloalkyl medE means hydrogen, alkyl with 1-3 carbon atoms, cycloalkyl with
3-7 karbonatomer, med cykloalkyl med 3-7 karbonatomer monosubstitu- 3-7 carbon atoms, with cycloalkyl with 3-7 carbon atoms monosubstitu-
ert alkyl med 1-3 karbonatomer eller en gruppe pea alkyl with 1-3 carbon atoms or a group
hvori m betyr et helt tall fra 0 til h og R^ og R^ har den ovennevnte betydning, where m means an integer from 0 to h and R^ and R^ has the above meaning,
reduseres i forbindelser med formel IIIis reduced in compounds of formula III
hvori R;j" har den ovennevnte betydning og D betyr alkoksy med 1 - h karbonatomer eller har den for E angitte betydning, en COD-gruppe til en CH E-gruppe. in which R;j" has the above-mentioned meaning and D means alkoxy with 1 - h carbon atoms or has the meaning given for E, a COD group to a CH E group.
2 2
Fremgangsmåten i henhold til oppfinnelsen kan gjennomfares analogt med kjente metoder. The method according to the invention can be carried out analogously to known methods.
Ved fremgangsmåten a) går man f.eks. frem under betingelseneIn procedure a), one goes, e.g. forward under the conditions
for en alkylering av et sekundært amin. Fremgangsmåten a) be-tegnes derfor i det folgende som alkylering. Man alkylerer forbindelsene med formel II f. eks. y, eå omsetning med en forbindelse med formel V for an alkylation of a secondary amine. Method a) is therefore referred to in the following as alkylation. The compounds of formula II are alkylated, e.g. y, eå reaction with a compound of formula V
hvori R^har den ovennevnte betydning og Y står for en ved en SN^-reaksjon avspaltbar rest, eller med andre kjente alkyleringsmidler, f.eks. med en forbindelse som kan erholdes fra en forbindelse ,%éd . formel V ved avspalting av HY. Y betyr f.eks. syreresten av en reaksjonsdyktig ester, f.eks. halogen som klor, brom eller iod, foretrukket klor eller brom, eller syrerestene av en organisk sulfonsyre, f.eks. en alkylsulfonyloksyrest som metylsulfonyloksy, eller en arylsulfonyloksyrest som fenylsulfonyloksy eller p-tolylsulfonyloksy. in which R^ has the above-mentioned meaning and Y stands for a residue that can be cleaved by an SN^ reaction, or with other known alkylating agents, e.g. with a compound obtainable from a compound ,%éd . formula V by cleavage of HY. Y means e.g. the acid residue of a reactive ester, e.g. halogen such as chlorine, bromine or iodine, preferably chlorine or bromine, or the acid residues of an organic sulphonic acid, e.g. an alkylsulfonyloxy acid residue such as methylsulfonyloxy, or an arylsulfonyloxy acid residue such as phenylsulfonyloxy or p-tolylsulfonyloxy.
Alkyleringen av forbindelsene med formel II med forbindelsene med formel V gjennomfores hensiktsmessig i et organisk løsningsmiddel, f.eks. i et amid av en alifatisk karboksylsyre som f.esk. dimetylformamid eller i et aromatisk hydrokarbon som toluen. Man arbeider med fordel i nærvær av et basisk kondensasjonsmiddel, f.eks. et alkaliemetallkarbonat som kaliumkarbonat. Reaksjonstemperaturen kan variere mellom romtemperatur til omtrent 120°C og man arbeider foretrukket ved tilbakelogstemperaturen. The alkylation of the compounds of formula II with the compounds of formula V is conveniently carried out in an organic solvent, e.g. in an amide of an aliphatic carboxylic acid such as e.g. dimethylformamide or in an aromatic hydrocarbon such as toluene. It is advantageous to work in the presence of a basic condensation agent, e.g. an alkali metal carbonate such as potassium carbonate. The reaction temperature can vary between room temperature to approximately 120°C and one preferably works at the reflux temperature.
Egnede forbindelser, som kan erholdes fra en forbindelse med form;el V ved avspalting av HY, er bl.a. a, p-umettede karbonylforbindelser, for innforing av en rest (CH^^-COA Suitable compounds, which can be obtained from a compound of formula V by cleavage of HY, are, among other things, a, p-unsaturated carbonyl compounds, for the introduction of a residue (CH^^-COA
eller or
hvori A, R^og R^har den oven- in which A, R^and R^ have the above-
nevnte betydning, og 1,2-alkylenoksyder for innforing av en 2-hydroksyalkylgruppe. Omsetningen av forbindelser med formel II med oc,S-umettede karbonyl-forbindelser som metylvinylketon eller akrylsyre, lavere alkylester, skjer hensiktsmessig i et egnet organisk løsningsmiddel, f.eks. iseddik, en lavere alkanol som metanol, etanol og under omroring. Reaksjonstemperaturen kan variere mellom romtemperatur og tilbakelopstemperaturen for reaksjonsblandingen, foretrukket oppvarmes reaksjonsblandingen til omtrent 20 - 80°C. said meaning, and 1,2-alkylene oxides for the introduction of a 2-hydroxyalkyl group. The reaction of compounds of formula II with oc,S-unsaturated carbonyl compounds such as methyl vinyl ketone or acrylic acid, lower alkyl ester, conveniently takes place in a suitable organic solvent, e.g. glacial acetic acid, a lower alkanol such as methanol, ethanol and under stirring. The reaction temperature can vary between room temperature and the reflux temperature for the reaction mixture, preferably the reaction mixture is heated to approximately 20 - 80°C.
Ved omsetningen av forbindelsene med formel II med 1,2-alkylenoksyder kan reaksjonstemperaturen variere mellom omtrent -10 og 100°C. In the reaction of the compounds of formula II with 1,2-alkylene oxides, the reaction temperature can vary between approximately -10 and 100°C.
Grupper av resten R2, som under betingelsene for fremgangsmåten Groups of the residue R2, as under the conditions of the method
a) ikke er inerte, kan beskyttes og avspaltes etter innforing av den beskyttede rest R^i 1-stillingen av forbindelsene med formel a) are not inert, can be protected and cleaved after introduction of the protected residue R^in the 1-position of the compounds of formula
II. Således kan man f.eks. erholde sluttforbindelser med formel Ib II. Thus, one can e.g. obtain final compounds of formula Ib
hvori r betyr et helt tall fra 1 til ? og L , R-, og R*har den ovennevnte betydning, ved at en rest hvori r, R^og R^har den ovennevnte betydning, i form av et katal analogt med de ovenfor beskrevne metoder 1 innfores i 1-stillingen av en forbindelse med formel II og fra de således erholdte, beskyttede slutt-f orbindelser, f. eks. med formel VI- where r means an integer from 1 to ? and L , R-, and R* have the above-mentioned meaning, in that a residue in which r, R^ and R^ have the above-mentioned meaning, in the form of a catal analogous to the methods described above 1 is introduced in the 1-position by a compound with formula II and from the protected end compounds thus obtained, e.g. with formula VI-
hvori Rp r, R^og R^har den ovennevnte betydning og enten R^ wherein Rp r, R^ and R^ have the above meaning and either R^
og R^' betyr alkyl med ^- k■ karbonatomer. eller R^og R^.' sammen står for en alkylrest med 2- h karbonatomer, avspaltes beskyttelses-gruppen henholdsvis beskyttelsesgruppene. and R^' means alkyl with ^-k■ carbon atoms. or R^and R^.' together stand for an alkyl residue with 2 h carbon atoms, the protecting group or the protecting groups are split off.
Bærer i forbindelsen med formel I karbonatomet i resten R^, som står i a-stilling til nitrogenatomet, et hydrogenatom og er R^inert under betingelsene for en reduserende alkylering, så kan denne rest også erholdes ved reduserende alkylering av forbindelsene med formel II med aldehytter eller ketoner som tilsvarer R^. Den reduserende alkylering kan gjennomfores etter kjente metoder, f.eks. hydrogenolyttisk eller etter Leuckart-Wallach. If in the compound of formula I the carbon atom in the residue R^, which is in the a-position to the nitrogen atom, bears a hydrogen atom and is R^inated under the conditions for a reductive alkylation, then this residue can also be obtained by reductive alkylation of the compounds of formula II with aldehydes or ketones corresponding to R^. The reductive alkylation can be carried out according to known methods, e.g. hydrogenolytic or according to Leuckart-Wallach.
Fremgangsmåten b) kan gjennomfores analogt med de for reduksjonProcedure b) can be carried out analogously to those for reduction
av tert-amider, henholdsvis N,N-disubstituerte ureotaner til tert-aminer kjente metoder. Man reduserer forbindelsene med formel III, f.eks. med eventuelt komplekse metallhydrider eller diboran. of tert-amides, respectively N,N-disubstituted ureotanes to tert-amines known methods. The compounds of formula III are reduced, e.g. with possibly complex metal hydrides or diborane.
Som metallhydrider er spesielt aluminiumhydrider som f.eks. aluminiumhydrid, dialkylaluminiumhydrider, lithiumaluminiumhydrid eller lithiumaluminium/aluminiumklorid egnet. As metal hydrides, aluminum hydrides such as e.g. aluminum hydride, dialkyl aluminum hydrides, lithium aluminum hydride or lithium aluminum/aluminum chloride suitable.
Generelt gjennomfores reduksjonen hensiktsmessig i et under reak-sjonsbetingelsene inert løsningsmiddel. Egnede løsningsmidler er f.eks. etere med åpen eller cyklisk kjede, f.eks. tetrahydrofuran. In general, the reduction is conveniently carried out in a solvent that is inert under the reaction conditions. Suitable solvents are e.g. open or cyclic ethers, e.g. tetrahydrofuran.
Reduksjonen kan gjennomfores ved omtrent romtemperatur til omtrent 100°C, f.eks. ved omtrent 30°C til koketemperaturer for reaksjons blandingen. Ved reduksjon av tertamider med formel III arbeider man foretrukket ved omtrent ho - 60°C, ved reduksjon av uretanene med formel III foretrukket ved koketemperaturen for reaksjonsblandingen. The reduction can be carried out at approximately room temperature to approximately 100°C, e.g. at about 30°C to boiling temperatures of the reaction mixture. In the reduction of tertamides of formula III, one preferably works at approximately ho - 60°C, in the reduction of the urethanes of formula III preferably at the boiling temperature of the reaction mixture.
Hvis det i forbindelsen med formel III foreligger en klor- eller brom-substituent, anvender man hensiktsmessig aluminiumhydrid eller et dialkylaluminiumhydrid som metallhydrid, men også diboran. If a chlorine or bromine substituent is present in the compound of formula III, aluminum hydride or a dialkyl aluminum hydride is suitably used as the metal hydride, but also diborane.
Fremgangsmåten b) egner seg spesielt for reduksjon av en N-alkoksy-karbonylgruppe til N-metylgruppen såvel for innforing av cyklo-propylmetylgruppen. Method b) is particularly suitable for the reduction of an N-alkoxycarbonyl group to the N-methyl group as well as for the introduction of the cyclopropylmethyl group.
Forbindelsene med formel I kan foreligge i fri form som base eller i form av addisjonssalter med syrer. The compounds of formula I can be present in free form as a base or in the form of addition salts with acids.
Fra de fri baser lar seg på kjent måte syreaddisjonssalter frem-stille og omvendt, f.eks. Bis-base-naftalin-1,5-disulfonat eller hydrogenmalonatet. Acid addition salts can be prepared from the free bases in a known manner and vice versa, e.g. Bis-base-naphthalene-1,5-disulfonate or hydrogen malonate.
Forbindelsene med formler II og III er nye og kan fremstilles analogt med kjente metoder. The compounds with formulas II and III are new and can be prepared analogously with known methods.
Forbindelsene med formel IlaThe compounds of formula IIa
hvori R^" har den ovennevnte betydning, kan f. eks. fremstilles ved avspalting av en alkoksykarbonyl beskyttelsesgruppe fra forbindelsene med formel Illa in which R^" has the above-mentioned meaning, can for example be prepared by removing an alkoxycarbonyl protecting group from the compounds of formula Illa
hvori r| har den ovennevnte betydning og alk står for alkyl med 1- k karbonatomer. in which r| has the above meaning and alk stands for alkyl with 1-k carbon atoms.
Eterspalting av en forbindelse med formel Ila, hvori r| betyr alkoksy med 1- h karbonatomer, med f.eks. Lewis-syrer eller med alkalimetallhydrid-mercaptan som natriumhydrid/metylmercaptan gir det tilsvarende hydroksyderivat. Ether cleavage of a compound of formula IIa, wherein r| means alkoxy with 1-h carbon atoms, with e.g. Lewis acids or with alkali metal hydride mercaptan such as sodium hydride/methyl mercaptan gives the corresponding hydroxy derivative.
Forbindelsene med formel Illa kan f.eks. fremstilles ved hjelpThe compounds with formula Illa can e.g. produced using
av en Grignard-syntese fra forbindelsen med formel IV, hvori alk har den ovennevnte betydning. Omsetningen forloper stereo-spesifik. of a Grignard synthesis from the compound of formula IV, wherein alk has the above meaning. The turnover proceeds stereo-specifically.
N-acyleringen, henholdsvis N-formulering av forbindelsene ved formejyll gir de tilsvarende NCOD-derivater med formel III, hvori har den for E angitte betydning. The N-acylation, respectively N-formulation of the compounds by formejyl gives the corresponding NCOD derivatives of formula III, in which E has the meaning indicated.
Forbindelsene med formel IV hvori alk betyr etyl er kjent. De ovrige forbindelser med formel IV kan fremstilles analogt med denne forbindelse. The compounds of formula IV in which alk means ethyl are known. The other compounds of formula IV can be prepared analogously to this compound.
I den grad fremstilling av ut;gangsf orbindelsene ikke er beskrevet er disse kjente eller kan fremstilles etter de i og for seg kjente fremgangsmåter, henholdsvis analogt med de her beskrevne eller analogt med i og for seg kjente metoder. To the extent that the preparation of the starting compounds is not described, these are known or can be prepared according to methods known per se, respectively analogously to those described here or analogously to methods known per se.
Forbindelsen med formel I i fri form eller i form av deres physio-logisk tålbare addisjonssalter med syrer, i det folgende betegnet som substanser med formel I, har en interessant farmakodynamisk The compound of formula I in free form or in the form of their physiologically tolerable addition salts with acids, hereinafter referred to as substances of formula I, has an interesting pharmacodynamic
egenskap, og kan folgelig anvendes som legemiddel.property, and can therefore be used as medicine.
De fremviser en antiarrytmisk virkning, og på grunn av denne virkning er de egnet for behandling av hjerterytme-forstyrrelser. They exhibit an antiarrhythmic effect, and because of this effect they are suitable for the treatment of heart rhythm disturbances.
For anvendelse som anti-arrytmika egner seg spesielt substansene med formel I, hvori R. betyr hydrogen, 3-me"toksy, ^--rnetyl, ^f-fluor eller ^--klor, såvel som substansene med formel I, hvori R^ betyr metyl, allyl, en gruppe (CH^) -CO-CH^, hvori p har den ovennevnte betydning, fenylalkyl med 7-10 karbonatomer, fenoksyalkyl med 8-9 karbonatomer, 3-p-klorfenylthiopropyl, 3-p-klorfenylsulfonyl- For use as anti-arrhythmics, the substances of formula I, in which R is hydrogen, 3-methoxy, β-methyl, β-fluorine or β-chloro, as well as the substances of formula I, in which R ^ means methyl, allyl, a group (CH^)-CO-CH^, wherein p has the above meaning, phenylalkyl of 7-10 carbon atoms, phenoxyalkyl of 8-9 carbon atoms, 3-p-chlorophenylthiopropyl, 3-p-chlorophenylsulfonyl -
propyl eller en gruppe propyl or a group
hvori r har den ovennevnte betydning, R^ betyr hydrogen, fluor, klor eller metyl og R^ betyr hydrogen eller metyl. wherein r has the above meaning, R 1 means hydrogen, fluorine, chlorine or methyl and R 2 means hydrogen or methyl.
Substansene med formel I fremviser dertil en antidepressiv virkning, og er p.g.a. denne virkning egnet for behandling av depre-sjoner. The substances with formula I also exhibit an antidepressant effect, and are due to this effect suitable for the treatment of depression.
For anvendelsen som antidepresiva egner seg spesielt substansene med formel I hvori R^betyr ^--klor såvel som substansene formel I, hvori R2betyr metyl, allyl eller 2-hydroksyetyl. For use as antidepressants, the substances of formula I in which R 2 is chloro as well as the substances of formula I in which R 2 is methyl, allyl or 2-hydroxyethyl are particularly suitable.
Substansen kan anvendes i form av-preparater, f.eks. en losning eller en tablett som kan fremstilles etter kjente metoder, under anvendelse av vanlige hjelpe- og bærer-substanser. The substance can be used in the form of preparations, e.g. a solution or a tablet which can be prepared according to known methods, using usual auxiliary and carrier substances.
I de etterfølgende eksempler er alle temperaturangivelser i °C og er ukorrigert. In the following examples, all temperature indications are in °C and are uncorrected.
Eksempel 1; (3aRS, hSR, 7aRS)-heksahydro-1-fenetyl-M-fenyl-^-indolinol Example 1; (3aRS, hSR, 7aRS)-hexahydro-1-phenethyl-M-phenyl-^-indolinol
(fremgangsmåte a)(method a)
1^,8 g (3aRS,<I>fSR,7aRS)-heksahydro-If-fenyl-if-indolinol, 18,9 g fenetylbromid og 18g kaliumkarbonat oppvarmes i 15 timer under tilbakelop i 170 ml dimetylformamid. Etter avkjoling foretas inndamping og de utrystes med vann/etylacetat. Den organiske fase torres over natriumsulf at, f raf Utreres og inndampes (smeltepunkt av hydrogenmalonatet 133-135°C fra etanol/etylasetat). 1^.8 g of (3aRS,<I>fSR,7aRS)-hexahydro-If-phenyl-if-indolinol, 18.9 g of phenethyl bromide and 18 g of potassium carbonate are heated for 15 hours under reflux in 170 ml of dimethylformamide. After cooling, evaporation is carried out and they are shaken with water/ethyl acetate. The organic phase is dried over sodium sulfate, filtered and evaporated (melting point of the hydrogen malonate 133-135°C from ethanol/ethyl acetate).
Utgangsproduktet ble fremstilt på folgende måte:The starting product was produced in the following way:
a) Fenylmagnesiumbromid (fremstilt av ^fO g brombenzen og 5 g magnesium) omsettes med 30 g cis-he.ksahydro-^-okso-1 -indolin-karboksylsyre-etylester i tetrahydrofuran. Etter h timers omroring i romtemperatur, tilsettes reaksjonsblandingen 100 ml 2N saltsyre og 200 ml eter. Den organiske fase fraskilles, vaskes med vann og torres over natriumsulfat. Etter avdamping av eteren blir (3aRS,^SR,7aRS)-heksahydro-^-hydroksy-l+-fenyl-1 -indolin-karboksylsyre-etyléjeter tilbake som en olje. b) 30 g (3aRS,<!>+SR,7aRS)-he.ksahydro-<l>+-hydroksy-<l>+-fenyl-1-indolin-karboksylsyre-etylester loses i 300 ml metanol, og etter tilsetning av 300 ml 10N natriumhydroksyd omrores over natten ved koke-temperatur. Etter avkjoling ekstraheres grundig med metylenklorid. Metylenkloridfasen ekstraheres med 2N vinsyrelosning, den vanligs vinsyrelosning innstilles på nytt alkalisk og ekstraheres med metylenklorid. Etter vanlig opparbeidelse av den organiske fase erholdes (3aRS,<l>+SR,7aRS)-heksahydro-If-fenyl-^--indolinol (smeltepunkt av hydrogennaftalen-1,5-disulfonater 228 - 230°C fra etanol. a) Phenylmagnesium bromide (prepared from ^f0 g of bromobenzene and 5 g of magnesium) is reacted with 30 g of cis-hexahydro-^-oxo-1-indoline-carboxylic acid ethyl ester in tetrahydrofuran. After h hours of stirring at room temperature, 100 ml of 2N hydrochloric acid and 200 ml of ether are added to the reaction mixture. The organic phase is separated, washed with water and dried over sodium sulphate. After evaporation of the ether, (3aRS,^SR,7aRS)-hexahydro-^-hydroxy-1+-phenyl-1-indoline-carboxylic acid ethyl ether remains as an oil. b) 30 g of (3aRS,<!>+SR,7aRS)-hexahydro-<l>+-hydroxy-<l>+-phenyl-1-indoline-carboxylic acid ethyl ester are dissolved in 300 ml of methanol, and after addition of 300 ml of 10N sodium hydroxide is stirred overnight at boiling temperature. After cooling, extract thoroughly with methylene chloride. The methylene chloride phase is extracted with 2N tartaric acid solution, the usual tartaric acid solution is made alkaline again and extracted with methylene chloride. After normal work-up of the organic phase, (3aRS,<l>+SR,7aRS)-hexahydro-If-phenyl-^--indolinol is obtained (melting point of hydrogen naphthalene-1,5-disulfonates 228 - 230°C from ethanol.
Eksempel 2: (3aRS ,^-SR, 7aRS )-p-f luor-^f-(heksahydro-^-hydroksy-^--m-metoksyf enyl-1 -indolinyl )butyrof enon Example 2: (3aRS ,^-SR, 7aRS )-p-fluoro-^f-(hexahydro-^-hydroxy-^--m-methoxy enyl-1-indolinyl )butyrof enone
(fremgangsmåte a)(method a)
6g (3aRS,^-SR,7aRS)-heksahydro-<l>+-m-metoksyfenyl-<1>+-indolinol oppvarmes med 3 g 2-(3-klorpropyl)-2-p-fluorfenyldloksolan i 1 time ved 150°C. Den storknede smelte (3aRS ,>+SR, 7aRS)-1-(3-(2-p-fluor-f enyl-1 ,3-dioksolan-2-yl)-propyl m-metoksyf enyl- h-indolinol innstilles alkalisk med 2N natriumhydroksyd og ekstr.aheres grundig med metylenklorid. Den etter vanlig opparbeidelse erholdte olje-aktige rest loses i 165 ml aceton og settes bort med 16,5^1 2N saltsyre i ^-8 timer ved romtemperatur. Etter inndamping til torr-het, krystalliserer den i overskriften nevnte forbindelse fra etanol/eter som hydroklorid med smeltepunkt 168 - 170°C. 6g of (3aRS,^-SR,7aRS)-hexahydro-<l>+-m-methoxyphenyl-<1>+-indolinol is heated with 3 g of 2-(3-chloropropyl)-2-p-fluorophenyldloxolane for 1 hour at 150 °C. The solidified melt (3aRS,>+SR, 7aRS)-1-(3-(2-p-fluoro-phenyl-1,3-dioxolan-2-yl)-propyl m-methoxyphenyl-h-indolinol is adjusted alkaline with 2N sodium hydroxide and extracted thoroughly with methylene chloride. The oily residue obtained after normal work-up is dissolved in 165 ml of acetone and removed with 16.5^1 2N hydrochloric acid for ^-8 hours at room temperature. After evaporation to dryness , the compound mentioned in the title crystallizes from ethanol/ether as a hydrochloride with a melting point of 168 - 170°C.
Eksempel 3: (3aRS,*fSR,7aRS )-1+-p-klorfenyl-heksahydro-1 -metyl-^f-indolinol Example 3: (3aRS,*fSR,7aRS )-1+-p-chlorophenyl-hexahydro-1-methyl-^f-indolinol
(fremgangsmåte b)(method b)
1 5 g (3aRS,l+SR,7aRS)-l+-p-klorfenylheksahydro-l+-hydroksy-1 -indolin-karboksylsyre-etylester og k- g lithiumaluminiumhydrid i 100 ml tetrahydrofuran oppvarmes i 15 timer under tilbakelop. Overskudd av Lithiumaluminiumhydrid spaltes ved tilsetning av vann. For-deling mellom vann og eter gir etter fraskilling og vanlig opparbeidelse av den organiske fase den i overskriften nevnte forbindelse, som olje (smeltepunkt av basen 98 til 101°C fra eter/ petroleter). 15 g of (3αRS,1+SR,7αRS)-1+-p-chlorophenylhexahydro-1+-hydroxy-1-indoline-carboxylic acid ethyl ester and k-g of lithium aluminum hydride in 100 ml of tetrahydrofuran are heated for 15 hours under reflux. Excess lithium aluminum hydride is decomposed by the addition of water. Partitioning between water and ether gives, after separation and normal work-up of the organic phase, the compound mentioned in the title, as an oil (melting point of the base 98 to 101°C from ether/petroleum ether).
Eksempel h: (3aRS,<!>+SR,7aRS)-if-p-klorfenyl-1 -cyklopropyl-S®iY.i~^®^S5§^y.^S2z<1>±liG^2ii22iExample h: (3aRS,<!>+SR,7aRS)-if-p-chlorophenyl-1 -cyclopropyl-S®iY.i~^®^S5§^y.^S2z<1>±liG^2ii22i
(fremgangsmåte b)(method b)
Til en losning av 1,3 g lithiumaluminiumhydrid i 30 ml tetrahydrofuran tilsettes en under oppvarming fremstilt losning av 5,2 (3aRS,1+SR,7aRS)-l+-p-klorfenyl-1 -cyklopropyl-karbonylheksa-hydro-^f:'indolinol i 30 ml tetrahydrofuran. Blandingen omrores i 30 min. ved 50°C, spaltes med mettet ammoniumsulfatlosning og filtreres. Det inndampede filtrat tilsMttes en konsentrert losning av naftalen-1,5-disulfonsyre. Etter tilsetning av eter krystalliserer bis (3aRS,^-SR,7aRS)-If-p-klorfenyl-1 -cyklo.p^ropyl-metylheksahydro-^-indolinol)naftalen-1,5-disulfonat med smeltepunkt 2h- 0 - 2h2°C. To a solution of 1.3 g of lithium aluminum hydride in 30 ml of tetrahydrofuran is added a solution of 5,2 (3aRS,1+SR,7aRS)-1+-p-chlorophenyl-1-cyclopropyl-carbonylhexa-hydro-^f prepared during heating: indolinol in 30 ml of tetrahydrofuran. The mixture is stirred for 30 min. at 50°C, decomposed with saturated ammonium sulfate solution and filtered. The evaporated filtrate is added to a concentrated solution of naphthalene-1,5-disulfonic acid. After addition of ether, bis (3aRS,^-SR,7aRS)-If-p-chlorophenyl-1-cyclo.propyl-methylhexahydro-^-indolinol)naphthalene-1,5-disulfonate crystallizes with melting point 2h- 0 - 2h2 °C.
Utgangsmaterialet kan fremstilles på folgende måte:The starting material can be produced in the following way:
Til en losning av 7,2 g (3aRS,>+SR,7aRS)-1+-p-klorfenyl-heksahydro-^--indolinol og 2,5 ml pyridin i 30 ml metylenklorid, tildryppes ved o - 10° en losning av 2,7<*>+ g cyklopropankarboksylsyreklorid. Blandingen omrores så i 1 time ved romtemperatur, utrystes der-etter i rekkefolge med ~\ 0% vinsyrelosning, natriumhydrogenkarbonat og mettet koksaltlosning, torres over natriumsulfat og inndampes, idet (3aRSj^-SR^aRS )-If-p-.klorfenyl-1 -cyklopropyl-karbonyl-heksahydro-^f-indolinol med smeltepunkt 167 - 169* erholdes. To a solution of 7.2 g (3aRS,>+SR,7aRS)-1+-p-chlorophenyl-hexahydro-^--indolinol and 2.5 ml of pyridine in 30 ml of methylene chloride, at o - 10° a solution is added dropwise of 2.7<*>+ g of cyclopropanecarboxylic acid chloride. The mixture is then stirred for 1 hour at room temperature, then shaken successively with ~\0% tartaric acid solution, sodium bicarbonate and saturated sodium chloride solution, dried over sodium sulfate and evaporated, as (3aRSj^-SR^aRS )-If-p-.chlorophenyl- 1-Cyclopropyl-carbonyl-hexahydro-β-indolinol with melting point 167 - 169* is obtained.
På analog måte erholdes, ved å gå ut fra de tilsvarende forbindelser med formel II (fremgangsmåten a) eller med formel III (fremgangsmåte b), folgende forbindelse med formel I: In an analogous way, by proceeding from the corresponding compounds with formula II (method a) or with formula III (method b), the following compound with formula I is obtained:
Claims (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1623674A CH601226A5 (en) | 1974-12-06 | 1974-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO754028L true NO754028L (en) | 1976-06-09 |
Family
ID=4415551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO754028A NO754028L (en) | 1974-12-06 | 1975-11-28 |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS5182262A (en) |
AT (1) | AT357147B (en) |
AU (1) | AU504180B2 (en) |
BE (1) | BE836290A (en) |
CA (1) | CA1065326A (en) |
CH (1) | CH601226A5 (en) |
DD (1) | DD123458A5 (en) |
DE (1) | DE2552563A1 (en) |
DK (1) | DK140723B (en) |
ES (1) | ES443200A1 (en) |
FI (1) | FI753351A (en) |
FR (2) | FR2313048A1 (en) |
GB (1) | GB1526309A (en) |
IL (1) | IL48603A (en) |
NL (1) | NL7514007A (en) |
NO (1) | NO754028L (en) |
NZ (1) | NZ179445A (en) |
SE (1) | SE408895B (en) |
SU (2) | SU625603A3 (en) |
ZA (1) | ZA757653B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4124719A (en) * | 1974-12-06 | 1978-11-07 | Sandoz Ltd. | -4-Phenylhexahydro-4-indolinol derivatives |
DE2741009A1 (en) | 1976-09-22 | 1978-03-23 | Sandoz Ag | 4-STYRYL-4-INDOLINOL DERIVATIVES, THEIR USE AND PRODUCTION |
-
1974
- 1974-12-06 CH CH1623674A patent/CH601226A5/xx not_active IP Right Cessation
-
1975
- 1975-11-24 DE DE19752552563 patent/DE2552563A1/en not_active Withdrawn
- 1975-11-27 DK DK537175AA patent/DK140723B/en unknown
- 1975-11-27 FI FI753351A patent/FI753351A/fi not_active Application Discontinuation
- 1975-11-28 SE SE7513457A patent/SE408895B/en unknown
- 1975-11-28 NO NO754028A patent/NO754028L/no unknown
- 1975-12-02 NL NL7514007A patent/NL7514007A/en not_active Application Discontinuation
- 1975-12-03 FR FR7537014A patent/FR2313048A1/en active Granted
- 1975-12-03 GB GB49614/75A patent/GB1526309A/en not_active Expired
- 1975-12-04 AU AU87277/75A patent/AU504180B2/en not_active Expired
- 1975-12-04 ES ES443200A patent/ES443200A1/en not_active Expired
- 1975-12-04 NZ NZ179445A patent/NZ179445A/en unknown
- 1975-12-04 DD DD189887A patent/DD123458A5/xx unknown
- 1975-12-04 CA CA241,104A patent/CA1065326A/en not_active Expired
- 1975-12-04 BE BE162462A patent/BE836290A/en unknown
- 1975-12-04 SU SU752194153A patent/SU625603A3/en active
- 1975-12-04 IL IL48603A patent/IL48603A/en unknown
- 1975-12-05 AT AT924775A patent/AT357147B/en not_active IP Right Cessation
- 1975-12-05 JP JP50144080A patent/JPS5182262A/ja active Pending
- 1975-12-05 ZA ZA757653A patent/ZA757653B/en unknown
-
1976
- 1976-08-12 FR FR7624662A patent/FR2308622A1/en not_active Withdrawn
-
1977
- 1977-02-07 SU SU772448706A patent/SU613720A3/en active
Also Published As
Publication number | Publication date |
---|---|
ZA757653B (en) | 1977-07-27 |
CA1065326A (en) | 1979-10-30 |
SE7513457L (en) | 1976-06-08 |
NL7514007A (en) | 1976-06-09 |
AU504180B2 (en) | 1979-10-04 |
DK140723C (en) | 1980-03-31 |
AT357147B (en) | 1980-06-25 |
IL48603A0 (en) | 1976-02-29 |
CH601226A5 (en) | 1978-06-30 |
IL48603A (en) | 1978-08-31 |
FR2308622A1 (en) | 1976-11-19 |
DK537175A (en) | 1976-06-07 |
SE408895B (en) | 1979-07-16 |
DE2552563A1 (en) | 1976-06-10 |
BE836290A (en) | 1976-06-04 |
JPS5182262A (en) | 1976-07-19 |
ATA924775A (en) | 1979-11-15 |
FI753351A (en) | 1976-06-07 |
DK140723B (en) | 1979-11-05 |
SU613720A3 (en) | 1978-06-30 |
SU625603A3 (en) | 1978-09-25 |
DD123458A5 (en) | 1976-12-20 |
FR2313048A1 (en) | 1976-12-31 |
NZ179445A (en) | 1978-03-06 |
GB1526309A (en) | 1978-09-27 |
FR2313048B1 (en) | 1979-09-21 |
ES443200A1 (en) | 1978-03-01 |
AU8727775A (en) | 1977-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2817593A1 (en) | MERCAPTOALKYLSULFONYLPROLINE DERIVATIVES AND RELATED COMPOUNDS | |
Louis et al. | Asymmetric nitrone-vinyl sulfoxide cycloadditions | |
US4361562A (en) | 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them | |
EP1421062A1 (en) | Novel cyclohexyl sulphones | |
PT1408961E (en) | 2 pyrrolidone derivatives as prostanoid agonists | |
WO1995030675A1 (en) | Biphenylcarboxamides useful as 5-ht1d antagonists | |
CS205087B2 (en) | Method of producing hydroxy-and oxoderivatives of aryloxy-and arylthio-perhydro-aza heterocycles | |
FR2758328A1 (en) | NOVEL AROMATIC AMINES DERIVED FROM CYCLIC AMINES USEFUL AS MEDICAMENTS | |
AU693336B2 (en) | Pyrrolidinyl hydroxamic acid compounds and their production process | |
NO754028L (en) | ||
CA1039731A (en) | Process for preparing new 2-methoxy-benzamide derivatives | |
FR2662442A1 (en) | N-SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES PROCESS FOR THEIR PREPARATION, INTERMEDIATES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
NL7809120A (en) | PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES. | |
IE913964A1 (en) | New imidazole compounds, process for the preparation thereof, and pharmaceutical compositions containing them | |
US4307110A (en) | Mercaptoacyl derivatives of 3-substituted proline derivatives | |
US3539579A (en) | 1 - (3 - cyano - 3,3 - diphenyl - propyl) - 4- phenyl - piperidine - 4 - carboxylic acid esters | |
Axelsson et al. | The nucleophilic ring‐opening of N‐benzylquinuclidinium bromide | |
EP0002792A1 (en) | 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them | |
IE50816B1 (en) | Novel indane derivatives,process for their preparation,their use as pharmaceuticals and pharmaceutical compositions containing said derivatives | |
DK150541B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 1- (3-BROMISOXAZOL-5-YL) -2-TERT.-BUTYL-AMINOETHANOL OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS. | |
IE45436B1 (en) | 12-azaprostanoic acid derivatives | |
US4124719A (en) | -4-Phenylhexahydro-4-indolinol derivatives | |
GB1575852A (en) | Hexahydro-4-indolinol derivatives | |
EP1019376A1 (en) | Pyridone derivatives, their preparation and their use as synthesis intermediates | |
FR2586417A1 (en) | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION |